Mr Fang Qi > Fangda Partners > Beijing, China > Lawyer Profile

Fangda Partners
27/F North Tower Beijing Kerry Centre
1 Guanghua Road Chaoyang District
Beijing 100020
China
Fang Qi photo

Work Department

Healthcare and life science, intellectual property

Position

Partner

Languages

Chinese, English

Memberships

Admitted to practice before the SIPO
Admitted to practice before the USPTO

Education

Columbia University School of Law, J.D.
City University of New York, Ph.D.,
Biochemistry Peking University, B.S., Biochemistry

Lawyer Rankings

China > Life sciences and healthcare: PRC firms

Fangda Partners houses ‘a highly competent team of life sciences and healthcare lawyers’, who are equipped to handle the whole life cycle of life sciences and health products’. Highly praised for its ability to combine expertise from many practice areas within the firm’, the practice assists a stellar list of clients with financings, rights issuances, regulatory compliance, licensing applications, IP disputes, and antitrust matters. With ‘many years of experience in the biomedical industry’, Shanghai-based Josh Shin regularly advises on distribution and collaboration agreements. In Beijing, Kate Yin focuses on regulatory compliance and enforcement actions while Fang Qi handles IP transactions and antitrust litigation. M&A, foreign investment and PE matters are the area of expertise of Shanghai-based Diana Li. Splitting his time between Beijing and Hong Kong, Michael Han is recommended for joint ventures and antitrust investigations. Sherry Yao departed in April 2022.

China > Intellectual property: PRC firms

Fangda Partners‘ appellate litigation and advocacy practice is known for successfully arguing cases before the provincial high courts and the PRC Supreme Court. In non-contentious matters, the team advises on transactions involving procurements and acquisitions, along with assignments and licensing concerning technology, brands, patents and copyrights. Representative deals range from franchising, distribution and outsourcing to joint ventures, M&A, strategic alliances, and technology research and development. Key figures include IP litigation specialist James Hu, patent litigator Alexandra Yang , and Fang Qi, whose track record covers patent, trade secret, trade mark, copyright and antitrust disputes. Other experienced partners include experienced litigator Dixon Zhang, as well as Hans She, Claudia Yun, Tian Tian, Devan Shao, Giant Hu and Richard Lin. At next generation partner level, Tingting Liao‘s practice covers patent litigation and invalidations, while Lin Qin and Zheng Gou are active counsels. In May 2022, former partner Gordon Gao joined King & Wood Mallesons.